Date published: 2025-9-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

Necrostatin-5 (CAS 337349-54-9)

5.0(1)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
2 [[3,4,5,6,7,8-hexahydro-3-(4-methoxyphenyl)-4-oxo[1]benzothieno[2, 3- d]pyrimidin-2-yl]thio]-acetonitrile; Nec-5
Application:
Necrostatin-5 is an inhibitor of necroptosis by indirect inhibition of RIP1 kinase
CAS Number:
337349-54-9
Molecular Weight:
383.49
Molecular Formula:
C19H17N3O2S2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Necrostatin-5 is an inhibitor of necroptosis (non-apoptotic cell death pathway) by indirect inhibition of RIP1 kinase. Necroptosis is defined as alternative active cell death pathway: Death-Domain Receptor (DRs, e.g. Fas/TNFR) mediated and caspase-inhibitor insensitive with specific morphology (nuclear condensation, organelle swelling, loss of plasma membrane integrity). The necrostatins have been discovered to inhibit this pathway by inhibition of the death domain receptor-associated adaptor kinase RIP1. Three distinct mechanisms appear to be involved: T-loop dependent inhibition by necrostatin-1 partially T-loop independent inhibition by necrostatin-3 and indirect inhibition of RIP1 by necrostatin-5, since necrostatin-5 is a potent inhibitor of immunnoprecipitated RIP1, but does not inhibit recombinant RIP1.


Necrostatin-5 (CAS 337349-54-9) References

  1. Formate assay in body fluids: application in methanol poisoning.  |  Makar, AB., et al. 1975. Biochem Med. 13: 117-26. PMID: 1
  2. Structure-activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5.  |  Wang, K., et al. 2007. Bioorg Med Chem Lett. 17: 1455-65. PMID: 17270434
  3. Identification of RIP1 kinase as a specific cellular target of necrostatins.  |  Degterev, A., et al. 2008. Nat Chem Biol. 4: 313-21. PMID: 18408713
  4. Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease.  |  Zhu, S., et al. 2011. Cell Death Dis. 2: e115. PMID: 21359116
  5. Study of cardioprotective effects of necroptosis inhibitors on isolated rat heart subjected to global ischemia-reperfusion.  |  Dmitriev, YV., et al. 2013. Bull Exp Biol Med. 155: 245-8. PMID: 24131001
  6. Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells.  |  Lou, YF., et al. 2014. PLoS One. 9: e97719. PMID: 24874286
  7. Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia.  |  González-Juarbe, N., et al. 2015. PLoS Pathog. 11: e1005337. PMID: 26659062
  8. Infiltrated Macrophages Die of Pneumolysin-Mediated Necroptosis following Pneumococcal Myocardial Invasion.  |  Gilley, RP., et al. 2016. Infect Immun. 84: 1457-69. PMID: 26930705
  9. Effects of necrostatin-1, an inhibitor of necroptosis, and its inactive analogue Nec-1i on basal cardiovascular function.  |  Szobi, A., et al. 2016. Physiol Res. 65: 861-865. PMID: 27875900
  10. The Neuroprotective Effects of Necrostatin-1 on Subarachnoid Hemorrhage in Rats Are Possibly Mediated by Preventing Blood-Brain Barrier Disruption and RIP3-Mediated Necroptosis.  |  Chen, J., et al. 2019. Cell Transplant. 28: 1358-1372. PMID: 31370690
  11. Context specificity of the EMT transcriptional response.  |  Cook, DP. and Vanderhyden, BC. 2020. Nat Commun. 11: 2142. PMID: 32358524
  12. Inhibition of Necroptosis to Prevent Long-term Cardiac Damage During Pneumococcal Pneumonia and Invasive Disease.  |  Beno, SM., et al. 2020. J Infect Dis. 222: 1882-1893. PMID: 32492702
  13. Necrostatin-5 limits infarct size in the isolated rat heart  |  Y. Dmitriev, S. Minasian, E. Demchenko, M. Galagudza. 2013. European Heart Journal. 34: 5538.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Necrostatin-5, 5 mg

sc-215545
5 mg
$46.00

Necrostatin-5, 25 mg

sc-215545A
25 mg
$255.00